Latest News about FDA
Recent news which mentions FDA
Cannabis Pharmaceuticals: Company With Ties To Groundbreaking Medical Developments Pursues Cannabinoid-Based Medicines
August 02, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Tickers
NEWS
From Benzinga
From Benzinga
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
July 29, 2024
From Benzinga
Harris Vs. Trump: Will Cannabis Rescheduling Survive Biden's Exit? Analyst On Potential GOP Victory
July 24, 2024
From Benzinga
EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
July 23, 2024
From Benzinga
Allarity Therapeutics Hit By SEC Notice Related Disclosures Of Once Lead Cancer Program
July 22, 2024
From Benzinga
From Benzinga
FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban
July 17, 2024
From Benzinga
Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD
July 12, 2024
From Benzinga
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
July 11, 2024
From Benzinga
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
July 11, 2024
From Benzinga
FDA Approves Expanded Use Of Arcutis Biotherapeutics' Eczema Drug For Patients As Young As 6 Years
July 10, 2024
From Benzinga
Why Is Longeveron Stock Soaring On Wednesday?
July 10, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.